{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:45:55Z","timestamp":1791395155509,"version":"4.3.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["U10CA180819"],"award-info":[{"award-number":["U10CA180819"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["U10CA180888"],"award-info":[{"award-number":["U10CA180888"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1245\/s10434-022-12863-9","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T16:16:05Z","timestamp":1673280965000},"page":"1354-1363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)"],"prefix":"10.1245","volume":"30","author":[{"given":"Sepideh","family":"Gholami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Ben-Josef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony B.","family":"El-Khoueiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Blanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Kachnic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed A.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio G.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"issue":"43","key":"12863_CR1","doi-asserted-by":"publisher","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","volume":"21","author":"TO Goetze","year":"2015","unstructured":"Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211\u20137.","journal-title":"World J Gastroenterol."},{"issue":"2","key":"12863_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11605-006-0018-6","volume":"11","author":"RE Schwarz","year":"2007","unstructured":"Schwarz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on US population data. J Gastrointest Surg. 2007;11(2):158\u201365.","journal-title":"J Gastrointest Surg."},{"issue":"23","key":"12863_CR3","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","volume":"29","author":"MC de Jong","year":"2011","unstructured":"de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140\u20135.","journal-title":"J Clin Oncol."},{"key":"12863_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103328","volume":"163","author":"AA Azizi","year":"2021","unstructured":"Azizi AA, Lamarca A, McNamara MG, Valle JW. Chemotherapy for advanced gallbladder cancer (GBC): a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2021;163:103328.","journal-title":"Crit Rev Oncol Hematol."},{"issue":"5","key":"12863_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.21037\/cco.2016.10.09","volume":"5","author":"L Marcano-Bonilla","year":"2016","unstructured":"Marcano-Bonilla L, Mohamed EA, Mounajjed T, Roberts LR. Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations. Chin Clin Oncol. 2016;5(5):61.","journal-title":"Chin Clin Oncol."},{"issue":"6","key":"12863_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/01.sla.0000219737.81943.4e","volume":"243","author":"Y Fong","year":"2006","unstructured":"Fong Y, Wagman L, Gonen M, Crawford J, Reed W, Swanson R, et al. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg. 2006;243(6):767\u201371 (discussion 771-4).","journal-title":"Ann Surg."},{"issue":"1","key":"12863_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.hpb.2017.08.025","volume":"20","author":"JLA van Vugt","year":"2018","unstructured":"van Vugt JLA, Gaspersz MP, Coelen RJS, Vugts J, Labeur TA, de Jonge J, et al. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB (Oxford). 2018;20(1):83\u201392.","journal-title":"HPB (Oxford)."},{"issue":"8","key":"12863_CR8","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/cncr.11699","volume":"98","author":"WR Jarnagin","year":"2003","unstructured":"Jarnagin WR, Ruo L, Little SA, Klimstra D, D\u2019Angelica M, DeMatteo RP, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98(8):1689\u2013700.","journal-title":"Cancer."},{"issue":"60","key":"12863_CR9","first-page":"1612","volume":"51","author":"SW Park","year":"2004","unstructured":"Park SW, Park YS, Chung JB, Kang JK, Kim KS, Choi JS, et al. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection. Hepatogastroenterology. 2004;51(60):1612\u20138.","journal-title":"Hepatogastroenterology."},{"issue":"2","key":"12863_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-2008-1040466","volume":"10","author":"D Gonz\u00e1lez Gonz\u00e1lez","year":"1990","unstructured":"Gonz\u00e1lez Gonz\u00e1lez D, Gerard JP, Maners AW, De la Lande-Guyaux B, Van Dijk-Milatz A, Meerwaldt JH, et al. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis. 1990;10(2):131\u201341.","journal-title":"Semin Liver Dis."},{"issue":"1","key":"12863_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0360-3016(01)01764-3","volume":"52","author":"JJ Kresl","year":"2002","unstructured":"Kresl JJ, Schild SE, Henning GT, Gunderson LL, Donohue J, Pitot H, et al. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys. 2002;52(1):167\u201375.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"12863_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S1055-3207(02)00038-8","volume":"11","author":"OK Macdonald","year":"2002","unstructured":"Macdonald OK, Crane CH. Palliative and postoperative radiotherapy in biliary tract cancer. Surg Oncol Clin N Am. 2002;11(4):941\u201354.","journal-title":"Surg Oncol Clin N Am."},{"issue":"2","key":"12863_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0167-8140(91)90084-T","volume":"21","author":"M Mahe","year":"1991","unstructured":"Mahe M, Romestaing P, Talon B, Ardiet JM, Salerno N, Sentenac I, et al. Radiation therapy in extrahepatic bile duct carcinoma. Radiother Oncol. 1991;21(2):121\u20137.","journal-title":"Radiother Oncol."},{"issue":"3","key":"12863_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0167-8140(94)90355-7","volume":"33","author":"M Mahe","year":"1994","unstructured":"Mahe M, Stampfli C, Romestaing P, Salerno N, Gerard JP. Primary carcinoma of the gall-bladder: potential for external radiation therapy. Radiother Oncol. 1994;33(3):204\u20138.","journal-title":"Radiother Oncol."},{"issue":"3","key":"12863_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0360-3016(99)00472-1","volume":"46","author":"T Todoroki","year":"2000","unstructured":"Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, et al. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys. 2000;46(3):581\u20137.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"12863_CR16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1245\/s10434-018-6388-7","volume":"25","author":"I Nassour","year":"2018","unstructured":"Nassour I, Mokdad AA, Porembka MR, Choti MA, Polanco PM, Mansour JC, et al. Adjuvant therapy is associated with improved survival in resected perihilar cholangiocarcinoma: a propensity matched study. Ann Surg Oncol. 2018;25(5):1193\u2013201.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"12863_CR17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.ijrobp.2008.09.017","volume":"74","author":"ET Shinohara","year":"2009","unstructured":"Shinohara ET, Mitra N, Guo M, Metz JM. Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas. Int J Radiat Oncol Biol Phys. 2009;74(4):1191\u20138.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"12863_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijrobp.2010.05.001","volume":"81","author":"TZ Vern-Gross","year":"2011","unstructured":"Vern-Gross TZ, Shivnani AT, Chen K, Lee CM, Tward JD, MacDonald OK, et al. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2011;81(1):189\u201398.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"12863_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.ijrobp.2004.12.059","volume":"62","author":"BG Czito","year":"2005","unstructured":"Czito BG, Hurwitz HI, Clough RW, Tyler DS, Morse MA, Clary BM, et al. Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys. 2005;62(4):1030\u20134.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"12863_CR20","doi-asserted-by":"crossref","unstructured":"Baeza M, Reyes J, del Castillo C. Post-operative adjuvant radiochemotherapy in the treatment of gallbladder cancer. Presented at the 47th Annual Meeting of the American Society of Therapeutic Radiation Oncology: Denver, CO: 2005.","DOI":"10.1016\/j.ijrobp.2005.07.488"},{"issue":"1","key":"12863_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijrobp.2008.10.052","volume":"75","author":"DG Gold","year":"2009","unstructured":"Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, et al. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys. 2009;75(1):150\u20135.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"12863_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jso.21544","volume":"102","author":"SY Cho","year":"2010","unstructured":"Cho SY, Kim SH, Park SJ, Han SS, Kim YK, Lee KW, et al. Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol. 2010;102(1):87\u201393.","journal-title":"J Surg Oncol."},{"issue":"1","key":"12863_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jso.20831","volume":"96","author":"P Mojica","year":"2007","unstructured":"Mojica P, Smith D, Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol. 2007;96(1):8\u201313.","journal-title":"J Surg Oncol."},{"key":"12863_CR24","doi-asserted-by":"crossref","unstructured":"Mantripragada KC, Hamid F, Shafqat H, Olszewski AJ. Adjuvant therapy for resected gallbladder cancer: analysis of the national cancer data base. J Natl Cancer Inst. 2017;109(2).","DOI":"10.1093\/jnci\/djw202"},{"issue":"1","key":"12863_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.surg.2013.06.001","volume":"155","author":"O Hyder","year":"2014","unstructured":"Hyder O, Dodson RM, Sachs T, Weiss M, Mayo SC, Choti MA, et al. Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis. Surgery. 2014;155(1):85\u201393.","journal-title":"Surgery."},{"issue":"24","key":"12863_CR26","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","volume":"33","author":"E Ben-Josef","year":"2015","unstructured":"Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, et al. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33(24):2617\u201322.","journal-title":"J Clin Oncol."},{"issue":"5","key":"12863_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1159\/000518298","volume":"10","author":"SH Choi","year":"2021","unstructured":"Choi SH, Rim CH, Shin IS, Yoon WS, Koom WS, Seong J. Adjuvant radiotherapy for extrahepatic cholangiocarcinoma: a quality assessment-based meta-analysis. Liver Cancer. 2021;10(5):419\u201332.","journal-title":"Liver Cancer."},{"issue":"16","key":"12863_CR28","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","volume":"30","author":"AM Horgan","year":"2012","unstructured":"Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30(16):1934\u201340.","journal-title":"J Clin Oncol."},{"issue":"2","key":"12863_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00268-002-6434-1","volume":"27","author":"MF Gerhards","year":"2003","unstructured":"Gerhards MF, van Gulik TM, Gonz\u00e1lez Gonz\u00e1lez D, Rauws EA, Gouma DJ. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg. 2003;27(2):173\u20139.","journal-title":"World J Surg."},{"issue":"27","key":"12863_CR30","first-page":"1585","volume":"46","author":"T Todoroki","year":"1999","unstructured":"Todoroki T, Kawamoto T, Otsuka M, Koike N, Yoshida S, Takada Y, et al. Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer. Hepatogastroenterology. 1999;46(27):1585\u201391.","journal-title":"Hepatogastroenterology."},{"issue":"3","key":"12863_CR31","doi-asserted-by":"publisher","first-page":"E177","DOI":"10.1016\/j.ijrobp.2015.07.1001","volume":"93","author":"L Rosati","year":"2015","unstructured":"Rosati L, Charu V, Hacker-Prietz A, Zheng L, Cosgrove D, Pawlik T, et al. Adjuvant chemoradiation therapy in cholangiocarcinoma: a single-institution experience. Int J Radiat Oncol Biol Phys. 2015;93(3):E177.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"12863_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/SLA.0b013e31817f2bfd","volume":"248","author":"F Ito","year":"2008","unstructured":"Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Annals of Surgery. 2008;248(2):273\u20139.","journal-title":"Annals of Surgery."},{"issue":"2","key":"12863_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/SLA.0b013e31822238d8","volume":"254","author":"H Ito","year":"2011","unstructured":"Ito H, Ito K, D\u2019Angelica M, Gonen M, Klimstra D, Allen P, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg. 2011;254(2):320\u20135.","journal-title":"Ann Surg."},{"issue":"3","key":"12863_CR34","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.01.069","volume":"219","author":"JM Butte","year":"2014","unstructured":"Butte JM, Kingham TP, G\u00f6nen M, D\u2019Angelica MI, Allen PJ, Fong Y, et al. Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. J Am Coll Surg. 2014;219(3):416\u201329.","journal-title":"J Am Coll Surg."},{"issue":"2","key":"12863_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/1098-2388(200009)19:2<145::AID-SSU7>3.0.CO;2-6","volume":"19","author":"DL Bartlett","year":"2000","unstructured":"Bartlett DL. Gallbladder cancer. Semin Surg Oncol. 2000;19(2):145\u201355.","journal-title":"Semin Surg Oncol."},{"issue":"3","key":"12863_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/00000658-199809000-00011","volume":"228","author":"EC Burke","year":"1998","unstructured":"Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg. 1998;228(3):385\u201394.","journal-title":"Ann Surg."},{"issue":"4","key":"12863_CR37","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/SLA.0b013e3182822277","volume":"257","author":"T Aoba","year":"2013","unstructured":"Aoba T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Assessment of Nodal Status for Perihilar Cholangiocarcinoma: Location, Number, or Ratio of Involved Nodes. Ann Surg. 2013;257(4):718\u201325.","journal-title":"Ann Surg."},{"issue":"2","key":"12863_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0002-9610(92)90109-5","volume":"163","author":"Y Matsumoto","year":"1992","unstructured":"Matsumoto Y, Fujii H, Aoyama H, Yamamoto M, Sugahara K, Suda K. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg. 1992;163(2):239\u201345.","journal-title":"Am J Surg."},{"issue":"7","key":"12863_CR39","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11605-019-04244-7","volume":"24","author":"WJ Ma","year":"2020","unstructured":"Ma WJ, Wu ZR, Hu HJ, Wang JK, Yin CH, Shi YJ, et al. Extended lymphadenectomy versus regional lymphadenectomy in resectable hilar cholangiocarcinoma. J Gastrointest Surg. 2020;24(7):1619\u201329.","journal-title":"J Gastrointest Surg."},{"issue":"10","key":"12863_CR40","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/jamasurg.2016.1769","volume":"151","author":"F Giuliante","year":"2016","unstructured":"Giuliante F, Ardito F, Guglielmi A, Aldrighetti L, Ferrero A, Calise F, et al. Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an italian multicenter analysis. JAMA Surg. 2016;151(10):916\u201322.","journal-title":"JAMA Surg."},{"issue":"3","key":"12863_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/00000658-200103000-00013","volume":"233","author":"Y Kitagawa","year":"2001","unstructured":"Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233(3):385\u201392.","journal-title":"Ann Surg."},{"key":"12863_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jss.2018.10.044","volume":"236","author":"X Li","year":"2019","unstructured":"Li X, Lin H, Sun Y, Gong J, Feng H, Tu J. Prognostic significance of the lymph node ratio in surgical patients with distal cholangiocarcinoma. J Surg Res. 2019;236:2\u201311.","journal-title":"J Surg Res."},{"issue":"4","key":"12863_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/bjs.9752","volume":"102","author":"M Kiriyama","year":"2015","unstructured":"Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, Shimizu Y. Nagoya Surgical Oncology Group. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg. 2015;102(4):399\u2013406.","journal-title":"Br J Surg."},{"key":"12863_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1477-7819-10-87","volume":"10","author":"Y Shirai","year":"2012","unstructured":"Shirai Y, Sakata J, Wakai T, Ohashi T, Ajioka Y, Hatakeyama K. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes. World J Surg Oncol. 2012;10:87.","journal-title":"World J Surg Oncol."},{"issue":"5","key":"12863_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):63\u2013673.","journal-title":"Lancet Oncol."},{"issue":"35","key":"12863_CR46","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1200\/JCO.2010.33.8020","volume":"29","author":"SJ Wang","year":"2011","unstructured":"Wang SJ, Lemieux A, Kalpathy-Cramer J, Ord CB, Walker GV, Fuller CD, et al. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol. 2011;29(35):4627\u201332.","journal-title":"J Clin Oncol."},{"issue":"11","key":"12863_CR47","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.12998\/wjcc.v7.i11.1242","volume":"7","author":"T Koo","year":"2019","unstructured":"Koo T, Park H, Kim K. Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives. World J Clin Cases. 2019;7(11):1242\u201352.","journal-title":"World J Clin Cases."},{"issue":"8","key":"12863_CR48","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"T Takada","year":"2002","unstructured":"Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95(8):1685\u201395.","journal-title":"Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12863-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12863-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12863-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T14:17:29Z","timestamp":1676125049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12863-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["12863"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12863-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sepideh Gholami, Sarah Colby, David P. Horowitz, Katherine A. Guthrie, Edgar Ben-Josef, Anthony B. El-Khoueiry, Charles D. Blanke, Philip A. Philip, Lisa A. Kachnic, Syed A. Ahmad, and Flavio G. Rocha have no conflicts of interest to declare in relation to this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}